Literature DB >> 19487025

Relative abundance of full-length and truncated FOXP1 isoforms is associated with differential NFkappaB activity in Follicular Lymphoma.

Michael R Green1, Maher K Gandhi, Mark J Courtney, Paula Marlton, Lyn Griffiths.   

Abstract

FOXP1 is a transcriptional repressor that has been proposed to repress the expression of some NFkappaB-responsive genes. Furthermore, truncated forms of FOXP1 have been associated with a subtype of Diffuse Large B-cell Lymphoma characterised by constitutive NFkappaB activity, indicating that they may inhibit this repression. We have shown that FL tumors have increased relative abundance of truncated FOXP1 isoforms and this is associated with increased expression of NFkappaB-associated genes. Our results provide strong evidence that relative FOXP1 isoform abundance is associated with NFkappaB activity in FL, and could potentially be used as a marker for this gene signature.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19487025     DOI: 10.1016/j.leukres.2009.05.004

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  13 in total

1.  Downregulation of FOXP2 promoter human hepatocellular carcinoma cell invasion.

Authors:  Xia Yan; Huiling Zhou; Tingting Zhang; Pan Xu; Shusen Zhang; Wei Huang; Linlin Yang; Xingxing Gu; Runzhou Ni; Tianyi Zhang
Journal:  Tumour Biol       Date:  2015-07-06

2.  miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1.

Authors:  Marek Mraz; Liguang Chen; Laura Z Rassenti; Emanuela M Ghia; Hongying Li; Kristen Jepsen; Erin N Smith; Karen Messer; Kelly A Frazer; Thomas J Kipps
Journal:  Blood       Date:  2014-05-01       Impact factor: 22.113

3.  Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.

Authors:  Anto Sam Crosslee Louis Sam Titus; Tanzeen Yusuff; Marlène Cassar; Elizabeth Thomas; Doris Kretzschmar; Santosh R D'Mello
Journal:  J Neurosci       Date:  2017-05-26       Impact factor: 6.167

4.  FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma.

Authors:  Matthew P Walker; Charles M Stopford; Maria Cederlund; Fang Fang; Christopher Jahn; Alex D Rabinowitz; Dennis Goldfarb; David M Graham; Feng Yan; Allison M Deal; Yuri Fedoriw; Kristy L Richards; Ian J Davis; Gilbert Weidinger; Blossom Damania; Michael B Major
Journal:  Sci Signal       Date:  2015-02-03       Impact factor: 8.192

5.  Inferring genome-wide functional modulatory network: a case study on NF-κB/RelA transcription factor.

Authors:  Xueling Li; Min Zhu; Allan R Brasier; Andrzej S Kudlicki
Journal:  J Comput Biol       Date:  2015-04       Impact factor: 1.549

6.  A miR-19 regulon that controls NF-κB signaling.

Authors:  Michael P Gantier; H James Stunden; Claire E McCoy; Mark A Behlke; Die Wang; Maria Kaparakis-Liaskos; Soroush T Sarvestani; Yuan H Yang; Dakang Xu; Sinéad C Corr; Eric F Morand; Bryan R G Williams
Journal:  Nucleic Acids Res       Date:  2012-06-07       Impact factor: 16.971

7.  Non-IG aberrations of FOXP1 in B-cell malignancies lead to an aberrant expression of N-truncated isoforms of FOXP1.

Authors:  Leila Rouhigharabaei; Julio Finalet Ferreiro; Thomas Tousseyn; Jo-Anne van der Krogt; Natalie Put; Eugenia Haralambieva; Carlos Graux; Brigitte Maes; Carmen Vicente; Peter Vandenberghe; Jan Cools; Iwona Wlodarska
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

8.  Gene expression profile analysis identifies metastasis and chemoresistance-associated genes in epithelial ovarian carcinoma cells.

Authors:  Liancheng Zhu; Zhenhua Hu; Juanjuan Liu; Jian Gao; Bei Lin
Journal:  Med Oncol       Date:  2014-12-11       Impact factor: 3.064

Review 9.  Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma.

Authors:  Max I Schreuder; Michiel van den Brand; Konnie M Hebeda; Patricia J T A Groenen; J Han van Krieken; Blanca Scheijen
Journal:  J Hematop       Date:  2017-09-25       Impact factor: 0.196

10.  NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer.

Authors:  Vladimir Kashuba; Alexey A Dmitriev; George S Krasnov; Tatiana Pavlova; Ilya Ignatjev; Vasily V Gordiyuk; Anna V Gerashchenko; Eleonora A Braga; Surya P Yenamandra; Michael Lerman; Vera N Senchenko; Eugene Zabarovsky
Journal:  Int J Mol Sci       Date:  2012-10-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.